Efficacy and Safety of Apantamide Combined With Docetaxel and ADT vs. Apantamide Combined With ADT in Patients With High Tumor Burden mHSPC: a Multicenter and Prospective Cohort Study
Clinical trial NCT05713578 · RECRUITING
Trial details
- NCT number
- NCT05713578
- Sponsor
- Qilu Hospital of Shandong University
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2026-02-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.